Management of hepatocellular carcinoma: Report of Consensus Meeting in the 45th Annual Meeting of the Japan Society of Hepatology (2009)
Article first published online: 14 JUL 2010
© 2010 The Japan Society of Hepatology
Volume 40, Issue 7, pages 667–685, July 2010
How to Cite
Arii, S., Sata, M., Sakamoto, M., Shimada, M., Kumada, T., Shiina, S., Yamashita, T., Kokudo, N., Tanaka, M., Takayama, T. and Kudo, M. (2010), Management of hepatocellular carcinoma: Report of Consensus Meeting in the 45th Annual Meeting of the Japan Society of Hepatology (2009). Hepatology Research, 40: 667–685. doi: 10.1111/j.1872-034X.2010.00673.x
- Issue published online: 14 JUL 2010
- Article first published online: 14 JUL 2010
- Received 23 December 2009; revision 3 March 2010; accepted 15 March 2010.
- hepatocellular carcinoma;
- Japan Society of Hepatology;
- staging system;
- treatment algorithm;
- consensus-based guideline
Hepatocellular carcinoma (HCC) is responsible for approximately 600 000–700 000 deaths worldwide. It is highly prevalent in the Asia–Pacific region and Africa, and is increasing in Western countries. The evidence-based guideline for HCC in Japan was published in 2005 and revised in 2009. Apart from this guideline, a consensus-based practice manual proposed by the HCC expert panel of the Japan Society of Hepatology (JSH), which reflects widely accepted daily practice in Japan, was published in 2007. At the occasion of the 45th Annual meeting of the JSH in Kobe 4–5 June 2009, a consensus meeting of HCC was held. Consensus statements were createdbased on 67% agreement of 200 expert members.This article describes the up-to-date consensus statements which largely reflect the real world HCC practice in Japan. We believe readers of this article will gain the newest knowledge and deep insight on the management of HCC proposed by consensus of the HCC expert members of JSH.